05 Jul 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Sweden-based Nolato is expanding its Chinese production facility with an additional 2,200 square metres, of which around 800 square metres will be clean room of the highest standard in accordance with ISO 14644-1:1999, class 8.
"China is the fastest growing market for pharmaceuticals and medical devices, which means that more and more of our customers are discussing expanded production in China for the Asian market," said Mr Christer Wahlquist, president of the Nolato Medical business area.
The expansion, which will accommodate around 30 injection moulding machines, is being made to allow us to stay one step ahead of our customers and secure resources for future growth in China, he added.
"Our philosophy is to be a close, long-term and reliable partner who can offer our customers global development and production facilities. The new facility will satisfy even the most demanding requirements of our customers," Mr Wahlquist added.
Nolato Medical has been active in China since 2008. Overall, Nolato Medical has around 25,000 square metres of clean room capacity in a range of classes at nine facilities in Asia, Europe and North America.